Skip to main content

Table 1 Eligibility criteria at the community- and individual-levels for the AVENIR mortality and resistance Stage I trial in Niger

From: Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)

Trial Level Eligibility Criteria
Mortality Community • Location in Dosso or Tahoua region
• Population between 250 and 2499a
• Distance > 5 km from district headquarters town
• Not designated as a “quartier” on national census
• Accessible and safe for study team
• Verbal consent from community leader(s)
Individual • Primary residence in a study community
• Age 1–59 months
• Weight ≥ 3.0
• No known allergy to macrolides
• Verbal consent of guardian for study participation
Resistance Community • Location in Dosso
• Accessible and safe for study team
• Randomly selected
• Not included in MORDOR trials
• Verbal consent of community leader(s)
Individual • Primary residence in a selected study community
• 1–59 months old, 7–12 years old or guardian of child eligible for treatment
• Randomly selected from census
• Verbal consent from guardian
  1. a Population size as estimated from the most recent national census or projections